Short answer · Medically reviewed summary · Last updated: 2026-04-07
The ICD-10 code for Microphthalmia is Q11.2 (Microphthalmos, unspecified), while the ICD-9 code historically used for this condition is 743.10. These codes are essential for medical documentation and billing in the clinical management of Microphthalmia, a condition characterized by one or both eyeballs being abnormally small. What is the clinical definition of Microphthalmia? Microphthalmia is a developmental disorder of the eye where the eyeball is significantly smaller than normal at birth.
The ICD-10 code for Microphthalmia is Q11.2 (Microphthalmos, unspecified), while the ICD-9 code historically used for this condition is 743.10. These codes are essential for medical documentation and billing in the clinical management of Microphthalmia, a condition characterized by one or both eyeballs being abnormally small.
Microphthalmia is a developmental disorder of the eye where the eyeball is significantly smaller than normal at birth. Clinically, it is defined by a total axial length of the eye that is at least two standard deviations below the mean for the patient's age. It is important to distinguish Microphthalmia from anophthalmia (the complete absence of ocular tissue), although they often exist on a clinical spectrum and can occur together. At DiseaseMaps.org, we recognize the unique challenges faced by our community members living with this condition, as it often impacts visual acuity, cosmetic appearance, and overall ocular health.
The etiology of Microphthalmia is highly heterogeneous, meaning it can arise from a wide array of factors. Research indicates that approximately 80% of cases are associated with genetic mutations, chromosomal abnormalities, or syndromic conditions. Over 100 genes have been implicated in the development of Microphthalmia, including SOX2, OTX2, and PAX6. In other instances, it may result from environmental exposures during pregnancy, such as infections (e.g., rubella, cytomegalovirus) or exposure to certain teratogenic substances. Because the genetic basis is so broad, clinical genetic testing is frequently recommended to determine the underlying cause.
Diagnosis typically occurs during a postnatal physical examination or via prenatal ultrasound imaging. Once diagnosed, management is multidisciplinary and focuses on maximizing visual potential and addressing structural concerns. Common clinical management strategies include:
Whether Microphthalmia is hereditary depends entirely on the specific genetic cause identified. It can follow autosomal dominant, autosomal recessive, or X-linked inheritance patterns, depending on the specific gene mutation involved. In many cases, it occurs sporadically as a *de novo* mutation. Because the inheritance patterns vary so widely, families are strongly encouraged to consult with a clinical geneticist to understand the recurrence risk for future pregnancies and the implications for extended family members.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.